{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:11:50Z","timestamp":1791357110358,"version":"4.3.1"},"reference-count":23,"publisher":"American Psychiatric Association Publishing","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["PS"],"published-print":{"date-parts":[[2003,10]]},"DOI":"10.1176\/appi.ps.54.10.1395","type":"journal-article","created":{"date-parts":[[2003,10,13]],"date-time":"2003-10-13T14:47:32Z","timestamp":1066056452000},"page":"1395-1401","source":"Crossref","is-referenced-by-count":106,"title":["Benzodiazepine Use and Abuse Among Patients With Severe Mental Illness and Co-occurring Substance Use Disorders"],"prefix":"10.1176","volume":"54","author":[{"given":"Mary F.","family":"Brunette","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas L.","family":"Noordsy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"Drake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"230","reference":[{"key":"R54101161","doi-asserted-by":"crossref","unstructured":"Licht RW: Drug treatment of mania: a critical review. Acta Psychiatrica Scandinavica 97:387\u2013397, 1998","DOI":"10.1111\/j.1600-0447.1998.tb10020.x"},{"key":"R54101162","doi-asserted-by":"crossref","unstructured":"Kupfer DJ: Pathophysiology and management of insomnia during depression. Annals of Clinical Psychiatry 11:267\u2013276, 1999","DOI":"10.3109\/10401239909147078"},{"key":"R54101163","unstructured":"Simpson GM: The treatment of tardive dyskinesia and tardive dystonia. Journal of Clinical Psychiatry 61(4 suppl):39\u201344, 2000"},{"key":"R54101164","doi-asserted-by":"crossref","unstructured":"Stimmel GL: Benzodiazepines in schizophrenia. Pharmacotherapy 16(6 Pt 2):148S-151S, 1996","DOI":"10.1002\/j.1875-9114.1996.tb03669.x"},{"key":"R54101165","doi-asserted-by":"crossref","unstructured":"Roache JD, Weisch RA: Findings from self-administration research on the addiction potential of benzodiazepines. Psychiatric Annals 25:153\u2013157, 1995","DOI":"10.3928\/0048-5713-19950301-08"},{"key":"R54101166","doi-asserted-by":"crossref","unstructured":"Johnson B, Longo LP: Considerations in the physician's decision to prescribe benzodiazepines to patients with addiction. Psychiatric Annals 28:160\u2013165, 1998","DOI":"10.3928\/0048-5713-19980301-12"},{"key":"R54101167","doi-asserted-by":"crossref","unstructured":"Miller NS: Liability and efficacy from long-term use of benzodiazepines: documentation and interpretation. Psychiatric Annals 25:166\u2013173, 1995","DOI":"10.3928\/0048-5713-19950301-10"},{"key":"R54101169","doi-asserted-by":"crossref","unstructured":"Sowers W, Golden S: Psychotropic medication management in persons with co-occurring psychiatric and substance use disorders. Journal Psychoactive Drugs 31:59\u201370, 1999","DOI":"10.1080\/02791072.1999.10471727"},{"key":"R541011610","doi-asserted-by":"crossref","unstructured":"Ciraulo DA, Nace EP: Benzodiazepine treatment of anxiety or insomnia in substance abuse. American Journal of Addictions 9:276\u2013279, 2000","DOI":"10.1080\/105504900750047346"},{"key":"R541011611","doi-asserted-by":"crossref","unstructured":"Ciraulo DA, Sands BF, Shader RI: Critical review of liability for benzodiazepine abuse among alcoholics. American Journal of Psychiatry 145:1501\u20131506, 1988","DOI":"10.1176\/ajp.145.12.1501"},{"key":"R541011612","unstructured":"Lukoff D, Nuechterlein KH, Ventura J: Manual for the expanded Brief Psychiatric Rating Scale (BPRS). Schizophrenia Bulletin 12:594\u2013602, 1986"},{"key":"R541011613","doi-asserted-by":"crossref","unstructured":"Drake RE, McHugo GJ, Clark RE, et al: Assertive community treatment for patients with co-occurring severe mental illness and substance use disorder: a clinical trial. American Journal of Orthopsychiatry 68:201\u2013215, 1998","DOI":"10.1037\/h0080330"},{"key":"R541011618","unstructured":"Clark RE, Ricketts SK, McHugo GJ: Measuring hospital use without claims: a comparison of patient and provider reports. Health Services Research 31:153\u2013169, 1996"},{"key":"R541011619","doi-asserted-by":"crossref","unstructured":"Lehman AF: A quality of life interview for the chronically mentally ill. Evaluation and Program Planning 11:51\u201362, 1988","DOI":"10.1016\/0149-7189(88)90033-X"},{"key":"R541011620","doi-asserted-by":"crossref","unstructured":"Wolford GL, Rosenberg SD, Oxman TE, et al: Evaluating current methods for detecting substance use disorder in persons with severe mental illness. Psychology of Addictive Behaviors 13:313\u2013326, 1999","DOI":"10.1037\/\/0893-164X.13.4.313"},{"key":"R541011621","doi-asserted-by":"crossref","unstructured":"Drake RE, Osher FC, Noordsy DL, et al: Diagnosis of alcohol use disorders in schizophrenia. Schizophrenia Bulletin 16:57\u201367, 1990","DOI":"10.1093\/schbul\/16.1.57"},{"key":"R541011622","doi-asserted-by":"crossref","unstructured":"McHugo GJ, Drake RE, Burton HL, et al: A scale for assessing the stage of substance abuse treatment in persons with severe mental illness. Journal of Nervous and Mental Disease 183:762\u2013767, 1995","DOI":"10.1097\/00005053-199512000-00006"},{"key":"R541011623","doi-asserted-by":"crossref","unstructured":"Liang KY, Zeger S: Longitudinal data analysis using generalized linear models. Biometrika 73:13\u201322, 1986","DOI":"10.1093\/biomet\/73.1.13"},{"key":"R541011626","doi-asserted-by":"crossref","unstructured":"Drake RE, Xie H, McHugo GJ, et al: The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia. Schizophrenia Bulletin 26:441\u2013449, 2000","DOI":"10.1093\/oxfordjournals.schbul.a033464"},{"key":"R541011627","doi-asserted-by":"crossref","unstructured":"Zimmet SV, Strous RD, Burgess ES, et al: Effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorder: a retrospective survey. Journal of Clinical Psychopharmacology 20:94\u201398, 2000","DOI":"10.1097\/00004714-200002000-00016"},{"key":"R541011628","doi-asserted-by":"crossref","unstructured":"Ross HE: Benzodiazepine use and anxiolytic abuse and dependence in treated alcoholics. Addiction 88:209\u2013218, 1993","DOI":"10.1111\/j.1360-0443.1993.tb00804.x"},{"key":"R541011629","doi-asserted-by":"crossref","unstructured":"Graham K, Wilsnack SC: The relationship between alcohol problems and use of tranquilizing drugs: longitudinal patterns among American women. Addictive Behaviors 25:13\u201328, 2000","DOI":"10.1016\/S0306-4603(99)00025-8"},{"key":"R541011631","doi-asserted-by":"crossref","unstructured":"Cuffel BJ, Chase P: Remission and relapse of substance use disorder in schizophrenia: results from a one-year prospective study. Journal of Nervous and Mental Disease 182:342\u2013348, 1994","DOI":"10.1097\/00005053-199406000-00006"}],"container-title":["Psychiatric Services"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ps.54.10.1395","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T16:35:27Z","timestamp":1731515727000},"score":1,"resource":{"primary":{"URL":"https:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ps.54.10.1395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10]]},"references-count":23,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2003,10]]}},"alternative-id":["10.1176\/appi.ps.54.10.1395"],"URL":"https:\/\/doi.org\/10.1176\/appi.ps.54.10.1395","relation":{},"ISSN":["1075-2730","1557-9700"],"issn-type":[{"value":"1075-2730","type":"print"},{"value":"1557-9700","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,10]]}}}